Astellas Pharma Inc. (ALPMF) Q3 2024 Earnings Call Transcript

Astellas Pharma Inc. (OTCPK:ALPMF) Q3 2024 Earnings Convention Name February 4, 2025 2:00 AM ET

Firm Individuals

Hiromitsu Ikeda – Chief Communications and IR Officer
Atsushi Kitamura – Chief Monetary Officer
Tadaaki Taniguchi – Chief Medical Officer
Claus Zieler – Chief Industrial Officer

Convention Name Individuals

Hidemaru Yamaguchi – Citigroup Securities
Seiji Wakao – JPMorgan Securities
Shinichiro Muraoka – Morgan Stanley MUFG Securities
Akinori Ueda – Goldman Sachs Securities
Hiroyuki Matsubara – Nomura Securities
Shinichiro Hyogo – Mitsubishi UFJ Belief Financial institution
Miki Sogi – Sanford C. Berstein
Fumiyoshi Sakai – UBS Securities
Kazuaki Hashiguchi – Daiwa Securities

Hiromitsu Ikeda

Thanks very a lot in your attendance on to this Q3 Y-to-D FY ’24 Monetary Outcomes Announcement Assembly. I’ll function a moderator. I am from — I am Communication — Chief Communications and IR Officer, Ikeda.

We’ll make a presentation first, and after that, we’ll have a Q&A session. The presentation is given primarily based upon the presentation materials posted on our web site, together with a Q&A. The simultaneous translation for each Japanese and English are supplied. For the simultaneous translation, the accuracy can’t be assured by us, the corporate. You possibly can choose the language from Zoom webinar display screen menu. If you choose the unique language, then you’ll be able to hear the unique sounds with out the interpreters’ voices.

That is some disclaimer. This materials or presentation by representatives for the corporate and solutions and assertion by representatives for the corporate within the Q&A session consists of forward-looking statements primarily based on assumptions and beliefs in mild of the knowledge presently out there to administration and topic to vital dangers and uncertainties.

Precise monetary outcomes could differ materially relying on various components. They comprise data on prescribed drugs, together with compounds beneath growth. This data will not be supposed to make any representations or commercials concerning the efficacy or effectiveness of